Access cutting-edge hypertrophic cardiomyopathy treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access hypertrophic cardiomyopathy specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypertrophic cardiomyopathy treatment provided free
This study is being conducted in order to understand the safety and effects of different doses of EDG-7500 as a single dose in adults with obstructive hypertrophic cardiomyopathy (oHCM) and as multiple doses in adults with obstructive or nonobstructive hypertrophic cardiomyopathy (nHCM).
Sponsor: Edgewise Therapeutics, Inc.
Check if you qualify for this hypertrophic cardiomyopathy clinical trial in Ann Arbor, MI
If you're searching for hypertrophic cardiomyopathy treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertrophic cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.